Fig. 4From: Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancerValidation of the CRL signature in the training, test and overall groups. a, b The distribution of the risk scores and OS status. c Prognostic signature signal heatmaps. d The K–M curves for survival status and survival time. e The ROC curve shows the potential of the prognostic CRL signature. f AUC curves comparing the prognostic accuracy of CRL signatureBack to article page